CXCL8 and colorectal cancer: Impressively, Wang et al. revealed a novel TME-associated mechanism by which CAF-induced IL8 mediates the phosphorylation of BRD4, leading to epigenetic remodeling and BET inhibitor resistance in colorectal cancer [47].